Latest Surrogate endpoint Stories

2014-03-18 23:26:23

Launch of ADDPLAN® 6.1 to Expedite and Improve Decision-Making in Clinical Trials Reston, Virginia (PRWEB) March 18, 2014 Aptiv Solutions, a global

2013-01-10 14:03:20

Spin and bias exist in a high proportion of published studies of the outcomes and adverse side-effects of phase III clinical trials of breast cancer treatments.

2010-06-21 14:00:00

SILVER SPRING, Md., June 21 /PRNewswire-USNewswire/ -- Pfizer Inc. today announced the voluntary withdrawal from the U.S. market of the drug Mylotarg (gemtuzumab ozogamicin) for patients with acute myeloid leukemia (AML), a bone marrow cancer. The company took the action at the request of the U.S.

2009-10-27 06:15:00

The FDA needs to be more effective in determining a drug’s efficiency after being approved, according to a report issued on Monday by the Government Accountability Office.

2009-01-12 14:00:00

Company Expects to Deliver Multiple Clinical Milestones throughout the Year; Amigal to Initiate Phase 3 Global Development in Second Quarter; Continued Strong Financial Position CRANBURY, N.J., Jan.

2008-09-17 15:00:11

MONTVALE, N.J., Sept. 17 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. today announced that a Letter to Stockholders is now posted to the Company's Web site http://www.synvista.com/.

2005-11-17 14:24:35

LONDON (Reuters) - Cholesterol-lowering drugs may help to delay the progression of Alzheimer's disease, the leading cause of dementia in the elderly, French scientists said on Thursday.

Word of the Day
  • An armed gangster.
The word 'shotta' is an alteration of 'shooter'.